ProteoNic Announces Licensing of its Premium 2G UNic Technology Platform for Production of Biologics to FyoniBio Read more
Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries Read more
Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH) Read more
Vaxart Announces Agreement with hVIVO to Develop World’s First Human Omicron Challenge Model Read more
Phanes Therapeutics’ PT886 granted Orphan Drug Designation for the treatment of pancreatic cancer by the FDA Read more
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology Read more
Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma Read more
Brii Biosciences Exercises Option for Vir Biotechnology’s VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China Read more